What is the correct weight‑based intravenous dosing and timing of indocyanine green (ICG) for hepatobiliary imaging and quantitative liver function testing?

ICG Dosing for Hepatobiliary Imaging and Liver Function Testing

For hepatobiliary imaging and quantitative liver function assessment, administer indocyanine green at 0.5 mg/kg intravenously as a rapid bolus injection into an arm vein, with the patient in a fasting, basal state. 1

Preparation and Administration Protocol

Patient Preparation

• Ensure fasting, basal state before ICG administration 1
• Weigh the patient accurately to calculate weight-based dosing 1

Reconstitution

• Add exactly 5 mL of aqueous solvent to the 25 mg vial, yielding a concentration of 5 mg/mL 1
• Prepare under sterile conditions 1

Injection Technique

• Inject rapidly into the lumen of an arm vein as a bolus 1
• Avoid extravasation outside the vein 1
• For photometric methods, withdraw 6 mL of venous blood from the patient's arm before injecting ICG for serum blank and standard curve construction 1

Timing for Sample Collection

For Percentage Retention Method (Simpler)

• Obtain a single blood sample at 20 minutes post-injection from the opposite arm 1
• Normal subjects should retain no more than 4% of initial dye concentration at 20 minutes 1

For Disappearance Rate Method (More Accurate)

• Obtain blood samples at 5,10,15, and 20 minutes after injection 1
• Plot values on semilogarithmic paper to calculate percentage disappearance rate 1

Normal Values and Interpretation

• Normal disappearance rate: 18-24% per minute 1
• Normal biological half-time: 2.5-3.0 minutes 1
• ICG clearance provides a stable measurement of hepatic blood flow due to absence of extra-hepatic removal 1

Alternative Monitoring Method

Ear densitometry can be used to monitor ICG appearance and disappearance without blood sampling, using a compensatory photo-electric cell to correct for blood volume and hematocrit changes 1. This technique permits simultaneous measurement of cardiac output, blood volume, and hepatic clearance 1.

Important Caveats

• Higher doses of ICG are particularly valuable for detecting drug-induced hepatic alterations and mild liver injury 1
• ICG is ideally suited for serial study of severe chronic liver disease due to exclusive hepatic clearance 1
• Temperature affects optical density - specimens containing ICG should be read at the same temperature 1
• Hemolysis does not interfere with percentage retention readings 1

Context: Hepatobiliary Contrast Agents in Imaging

While gadoxetic acid (a hepatobiliary MRI contrast agent) is taken up by hepatocytes via organic anion transporting polypeptides (OATP) and shows 80-90% of HCCs as hypointense on hepatobiliary phase imaging 2, extracellular contrast agents should be favored over gadoxetic acid for non-invasive HCC diagnosis due to superior diagnostic performance 2. ICG for functional testing serves a different purpose than these imaging contrast agents, providing quantitative assessment of hepatic clearance function rather than anatomic imaging.